Vi polysaccharide typhoid vaccine (Beijing Zhifei Luzhu Biopharmaceutical)

伤寒Vi多糖疫苗（智飞绿竹）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVi polysaccharide typhoid vaccine (Beijing Zhifei Luzhu Biopharmaceutical)
Drug Alias NameVi polysaccharide prophylactic typhoid vaccine
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTyphoid Fever
Global Approved IndicationsTyphoid Fever
Approved Indications in ChinaTyphoid Fever
Original Approved Country/TerritoryMainland China
Original Approved Date2014/06/06
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsTyphoid Fever
Inactive IndicationsN/A

Other Information

ATC CodeJ07AP03
Related LinksN/A